tryptophan has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Birková, A; Čižmárová, B; Hubková, B; Mareková, M; Valko-Rokytovská, M; Zábavníková, M | 1 |
Abernethy-Leinwand, A; Bouchard, DM; Collichio, FA; Ezzell, JA; Giglio, BC; Googe, PB; Ivanova, A; Ivanovic, M; Kowalski, MH; Lee, YZ; Li, Z; Long, PK; Meyers, MO; Moschos, SJ; Nikolaishvili-Feinberg, N; Oldan, JD; Ollila, DW; Smith, E; Thomas, NE; Trembath, DG; Wallack, DE; Wong, TZ; Zhao, W | 1 |
Azimi, A; Baumgartner, R; Hansson, J; Kamleh, MA; Ketelhuth, DFJ; Kiani, NA; Lundqvist, A; Morikawa, H; Rad Pour, S; Shafi, G; Shang, M; Tegnér, J; Wheelock, CE; Yang, M | 1 |
3 other study(ies) available for tryptophan and Dysplastic Nevus Syndrome, Hereditary
Article | Year |
---|---|
Tryptophan: Its Metabolism along the Kynurenine, Serotonin, and Indole Pathway in Malignant Melanoma.
Topics: Humans; Indoles; Kynurenine; Melanoma; Melanoma, Cutaneous Malignant; Serotonin; Skin Neoplasms; Tryptophan | 2022 |
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Kynurenine; Melanoma; Melanoma, Cutaneous Malignant; Prospective Studies; Tryptophan | 2023 |
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Topics: B7-H1 Antigen; CD4-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kynurenic Acid; Kynurenine; Melanoma; Melanoma, Cutaneous Malignant; Metabolic Networks and Pathways; Metabolomics; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Tryptophan; Tumor Microenvironment; Up-Regulation | 2019 |